BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kroes AC, Quint WG, Heijtink RA. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. J Med Virol. 1991;35:96-100. [PMID: 1765777 DOI: 10.1002/jmv.1890350205] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Wendel S. Rational testing for transmissible diseases. ISBT Science Series 2007;2:19-24. [DOI: 10.1111/j.1751-2824.2007.00098.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Domen RE, Yen-lieberman B, Nelson KA, Chua J, Sholtis W, Tyus H, Isada CM. Use of an HBV-DNA Hybridization Assay in the Evaluation of Equivocal Hepatitis B Virus Tests in Solid Organ Donors. Prog Transpl 2000;10:42-6. [DOI: 10.1177/152692480001000108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jilg W, Sieger E, Zachoval R, Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol. 1995;23:14-20. [PMID: 8530804 DOI: 10.1016/0168-8278(95)80305-x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
4 Fabrizi F, Bunnapradist S, Lunghi G, Villa M, Martin P. Transplanting Solid Organs from HBsAg Negative Donors Positive for Antibody to Hepatitis B Core Antigen: The Implications. The International Journal of Artificial Organs 2018;26:972-83. [DOI: 10.1177/039139880302601102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Weinberger KM, Zoulek G, Bauer T, B�hm S, Jilg W. A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 1999;58:105-10. [DOI: 10.1002/(sici)1096-9071(199906)58:2<105::aid-jmv1>3.0.co;2-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
6 Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R. Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol. 2007;40:312-317. [PMID: 17997353 DOI: 10.1016/j.jcv.2007.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
7 Narciso-Schiavon JL, Schiavon Lde L, Carvalho-Filho RJ, Emori CT, Maryia FA, Bordin JO, Silva AE, Ferraz ML. Clinical and epidemiological profile of female blood donors with positive serology for viral hepatitis B. Rev Soc Bras Med Trop 2015;48:524-31. [PMID: 26516960 DOI: 10.1590/0037-8682-0157-2015] [Reference Citation Analysis]
8 van Hoek B, Ringers J, Kroes AC, van Krieken JH, van Schelven WD, Masclee AA, van Krikken-Hogenberk LG, Haak HR, Lamers CB, Terpstra OT. Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B. J Hepatol 1995;23:109-18. [PMID: 7499780 DOI: 10.1016/0168-8278(95)80323-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
9 Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503 [PMID: 12854150 DOI: 10.3748/wjg.v9.i7.1501] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
10 Irwin L, Kotton CN, Elias N, Palafox J, Basler D, Shao SH, Lester W, Zhang X, Kimball B, Trencher C, Fishman JA. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety. Transpl Infect Dis 2017;19:e12791. [DOI: 10.1111/tid.12791] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
11 Zuckerman JN, Zuckerman AJ. Current topics in hepatitis B. J Infect. 2000;41:130-136. [PMID: 11023756 DOI: 10.1053/jinf.2000.0720] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.1] [Reference Citation Analysis]
12 Domen RE, Yen-Lieberman B, Nelson KA, Chua J, Sholtis W, Tyus H, Isada CM. Use of an HBV-DNA hybridization assay in the evaluation of equivocal hepatitis B virus tests in solid organ donors. Prog Transplant 2000;10:42-6. [PMID: 10941326 DOI: 10.7182/prtr.10.1.31037k70l5057170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
13 Almeida Neto C, Strauss E, Sabino EC, Sucupira MC, Chamone DA. Significance of isolated hepatitis B core antibody in blood donors from São Paulo. Rev Inst Med Trop Sao Paulo 2001;43:203-8. [PMID: 11557999 DOI: 10.1590/s0036-46652001000400005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
14 Quint WG, Fetter WP, van Os HC, Heijtink RA. Absence of hepatitis B virus (HBV) DNA in children born after exposure of their mothers to HBV during in vitro fertilization. J Clin Microbiol 1994;32:1099-100. [DOI: 10.1128/jcm.32.4.1099-1100.1994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
15 Janssen HLA, Schoenmaker-weber YAM, Kruining H, Schalm SW, Heijtink RA. Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays. J Med Virol 1993;40:307-12. [DOI: 10.1002/jmv.1890400408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kaminski G, Alnaqdy A, Al-belushi I, Nograles J, Al-dhahry SH. Evidence of Occult Hepatitis B Virus Infection among Omani Blood Donors: A Preliminary Study. Med Princ Pract 2006;15:368-72. [DOI: 10.1159/000094271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
17 Turner DP, Zuckerman M, Alexander GJ, Waite J, Wreghitt T. RISK OF INAPPROPRIATE EXCLUSION OF ORGAN DONORS BY INTRODUCTION OF HEPATITIS B CORE ANTIBODY TESTING: . Transplantation 1997;63:775-7. [DOI: 10.1097/00007890-199703150-00026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
18 Sato K, Ichiyama S, Iinuma Y, Nada T, Shimokata K, Nakashima N. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab. J Clin Microbiol 1996;34:1420-2. [PMID: 8735091 DOI: 10.1128/jcm.34.6.1420-1422.1996] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Koene RPM, Gotz HM, Van Den Hoek JAR, Heijnen MLA, Van Steenbergen JA, Kroes ACM. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups. Epidemiol Infect 2009;137:495-503. [DOI: 10.1017/s095026880800085x] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000;95:1316-1322. [PMID: 10811346 DOI: 10.1111/j.1572-0241.2000.01981.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
21 Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol. 2000;81:1165-1174. [PMID: 10769057 DOI: 10.1099/0022-1317-81-5-1165] [Cited by in Crossref: 143] [Cited by in F6Publishing: 150] [Article Influence: 6.5] [Reference Citation Analysis]
22 Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001;43:187-90. [PMID: 11798257 DOI: 10.1053/jinf.2001.0878] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
23 Jurinke C, Zöllner B, Feucht HH, van den Boom D, Jacob A, Polywka S, Laufs R, Köster H. Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera. Genet Anal 1998;14:97-102. [PMID: 9526701 DOI: 10.1016/s1050-3862(97)10006-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
24 Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci. 1997;18:49-53. [PMID: 10174292 DOI: 10.1016/s0955-3886(96)00076-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
25 Martlew VJ, Rogan PD, Shepherd AJN, Firth SA. Hepatitis B core antibody screening of voluntary blood donors: an extended pilot study using a modified passive haemagglutination assay. Transfus Med 1993;3:229-35. [DOI: 10.1111/j.1365-3148.1993.tb00120.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
26 Greub G, Frei PC. Presence of low levels of anti-HBs antibody in so-called ‘anti-HBc alone’ subjects: Low anti-HBs levels in anti-Hbc alone subjects. Liver 2001;21:380-3. [DOI: 10.1034/j.1600-0676.2001.210603.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]